Published on Medical Design Technology (https://www.mdtmag.com)

Home > Medtronic closes enrollment in drug-eluting balloon study | MassDevice.com On Call

Medtronic closes enrollment in drug-eluting balloon study | MassDevice.com On Call

Medical device titan Medtronic completes enrollment in its IN.PACT SFA II trial evaluating its IN.PACT Admiral drug-eluting balloon in treatment of peripheral artery disease.

MassDevice On Call

MASSDEVICE ON CALL — Minneapolis-based medical device company Medtronic [1] (NYSE:MDT [2]) announced closed enrollment in the U.S. arm of a study evaluating its IN.PACT Admiral drug-eluting balloon.

The multi-center study enrolled 181 patients with peripheral artery disease at more than 40 U.S. clinics, randomizing them to either receive treatment with the IN.PACT Admiral or a traditional, non-coated angioplasty balloon.

Content Item Type: 
News [3]
Meta Canonical URL: 
http://www.mdtmag.com/news/2013/01/medtronic-closes-enrollment-drug-eluting-balloon-study-massdevicecom-call
Summary: 
Medical device titan Medtronic completes enrollment in its IN.PACT SFA II trial evaluating its IN.PACT Admiral drug-eluting balloon in treatment of peripheral artery disease. MASSDEVICE ON CALL — Minneapolis-based medical device company Medtronic (NYSE:MDT) announced closed enrollment in the U.S. arm of a study evaluating its IN.PACT Admiral drug-eluting balloon. The multi-center study enrolled 181 patients with peripheral artery disease at more than 40 U.S. clinics, randomizing them to either receive treatment with the IN.PACT Admiral or a traditional, non-coated angioplasty balloon. News Well, Clinical Trials, On Callread more
Contributed Author: 
Mass Device
Legacy NID: 
139 056

Deeper Insights

<% if ( rc.ss_related_image_url != null ){ %>
?cmpid=regwallcontent&utm_source=Deeper%20Insights">">
<% } %>

?cmpid=regwallcontent&utm_source=Deeper%20Insights" + ""><%- rc.label %>

<% if ( rc.ss_search_logo != null ){ %> <% } %>
Advertisement
googletag.cmd.push(function() { googletag.display("dfp-ad-clone_of_wallpaper"); });
(function() { var _fbq = window._fbq || (window._fbq = []); if (!_fbq.loaded) { var fbds = document.createElement('script'); fbds.async = true; fbds.src = '//connect.facebook.net/en_US/fbds.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(fbds, s); _fbq.loaded = true; } _fbq.push(['addPixelId', '745881082149515']); })(); window._fbq = window._fbq || []; window._fbq.push(['track', 'PixelInitialized', {}]);
(function(d,s,i,r) { if (d.getElementById(i)){return;} var n=d.createElement(s),e=d.getElementsByTagName(s)[0]; n.id=i;n.src='//js.hs-analytics.net/analytics/'+(Math.ceil(new Date()/r)*r)+'/1743435.js'; e.parentNode.insertBefore(n, e); })(document,"script","hs-analytics",300000);
var _qevents = _qevents || []; (function() { var elem = document.createElement('script'); elem.src = (document.location.protocol == "https:" ? "https://secure" : "http://edge") + ".quantserve.com/quant.js"; elem.async = true; elem.type = "text/javascript"; var scpt = document.getElementsByTagName('script')[0]; scpt.parentNode.insertBefore(elem, scpt); })(); _qevents.push({ qacct:"p-jsEPJWTckjCbE" });
Quantcast
googletag.cmd.push(function () { googletag.display("dfp-ad-roadblock_modal"); });
googletag.cmd.push(function() { googletag.display("dfp-ad-roadblock_modal"); });
Source URL: https://www.mdtmag.com/news/2013/01/medtronic-closes-enrollment-drug-eluting-balloon-study-massdevicecom-call

Links
[1] http://www.massdevice.com/company/medtronic
[2] http://www.google.com/finance?q=mdt
[3] https://www.mdtmag.com/content-item-types/news